Blog

Julie Gralow: Submit your abstract to the UICC World Cancer Congress through April 4, 2024

Photo from Julie Gralow/Twitter

Mar 14, 2024, 22:22

Julie Gralow: Submit your abstract to the UICC World Cancer Congress through April 4, 2024

Julie Gralow shared a post by Union for International Cancer Control (UICC), on LinkedIn:

“Submit your abstract to the Union for International Cancer Control (UICC) World Cancer Congress through April 4, 2024.

Three submission categories:
1. Scientific studies describing collection, analysis and interpretation of cancer-relevant data (clinical, behavioural, epidemiological)
2. Summaries of practice, policy and advocacy reports with impact describing innovative cancer and NCD programs in detection, care, support, prevention, organization.
3. Summaries of fundraising campaign reports describing programs to build public support to fund or donate to cancer and NCD control causes”

Quoting Union for International Cancer Control (UICC)’s post:

“Don’t forget to submit your abstract for the 2024 World Cancer Congress in Geneva (17-19 September)!

Whether you are a renowned scientist, an experienced advocate, or a master at raising funds for the cause, we want to hear from you! Present your work at the World Cancer Congress and contribute to accelerating progress in global cancer control.”

Read further.

Source: Julie Gralow/LinkedIn and Union for International Cancer Control (UICC)/LinkedIn

Julie Gralow is the Chief Medical Officer (CMO) and Executive Vice President of the American Society of Clinical Oncology (ASCO). Previously, she was the Jill Bennett Endowed Professor of Breast Cancer at the University of Washington School of Medicine, Professor in the Clinical Research Division of the Fred Hutchinson Cancer Research Center, as well as Director of Breast Medical Oncology at the Seattle Cancer Care Alliance. She is the founder of the Women’s Empowerment Cancer Advocacy Network (WE CAN). Dr. Gralow received the ASCO Humanitarian Award in 2018 for her work in empowering women cancer patients and survivors globally.